Haystack Sciences CEO Eddie Watts sat down with Proactive at the BIO Investor Forum in San Francisco.
San Francisco-based, privately-held Haystack is developing methods for drug discovery to help find new cures for difficult-to-treat disorders using its indexer technology.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE
Basic Materials
CO2 GRO (CVE: GROW- OTCQB: BLONF) Vice President of Sales and Strategic Alliances Aaron Archibald joined Steve Darling from Proactive to bring details the company has seen very good results from their CO2 Delivery Solution commercial feasibility on greenhouse-grown peppers with Hidroexpo in...
Health
Industry & services
Retail & consumer
Finance
Mining
Prev article
